Second phase III study of BUPI for pain management in oral mucositis in cancer patients

Trial Profile

Second phase III study of BUPI for pain management in oral mucositis in cancer patients

Planning
Phase of Trial: Phase III

Latest Information Update: 08 Aug 2017

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Moberg Pharma
  • Most Recent Events

    • 08 Aug 2017 According to a Moberg Pharma media release, during the second quarter the company provided input on this study application for BUPI to their partner Cadila Pharmaceuticals.Submission preparations by Cadila are in the final stages.
    • 28 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top